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Edited by Robert BaroukiAbstract Yeast self-perpetuating amyloids (prions) provide a
convenient model for studying the cellular control of highly
ordered aggregates involved in mammalian protein assembly dis-
orders. The very ability of an amyloid to propagate a prion state
in yeast is determined by its interactions with the stress-inducible
chaperone Hsp104. Prion formation and propagation are also
inﬂuenced by other stress-related chaperones (Hsp70 and
Hsp40), and by alterations of the protein traﬃcking and degra-
dation networks. Some stress conditions induce prion formation
or loss. It is proposed that prions arise as byproducts of the
reversible assembly of highly ordered complexes, protecting cer-
tain proteins during unfavorable conditions.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Transmissible spongiform encephalopathies (TSEs), also
called prion diseases, attracted attention after the ‘‘mad
cow’’ disease outbreak in Europe in the 1990s, although other
examples of these diseases, such as sheep scrapie, human Cre-
utzfeldt-Jacob disease, etc., were known long ago (for review,
see [1]). A most unusual feature of these diseases is that infec-
tion is transmitted not by bacteria or viruses, but by protein-
based infectious particles (termed prions). The ‘‘protein only’’
model of TSE transmission, accepted by most researchers in
the ﬁeld, postulates that a speciﬁc mammalian protein (named
PrP) in an abnormal (‘‘prion’’) shape becomes an infectious
agent as it acquires an ability to convert the normally folded
host protein of the same sequence into a prion shape. Accord-
ing to one of the modiﬁcations of the prion model, the prion
isoform of PrP represents an ordered aggregate that can prolif-
erate by immobilizing the soluble PrP molecules [2]. Indeed,
PrP generates ﬁbrous b-rich ordered aggregates (called amy-
loids) in the brains of infected animals [1].
Amyloids formed by PrP resemble non-infectious amyloids
or amyloid-like aggregates associated with some other dis-
eases, including such neurodegenerative disorders as Alzhei-
mer disease (AD), Huntington disease (HD), Parkinson
disease (PD), etc. (for review, see [3]). Some of these diseases*Fax: +1 404 894 0519.
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doi:10.1016/j.febslet.2007.04.075are caused by mutations, e.g. by expansions of a polyglutamine
(poly-Q) stretch in a protein called huntingtin, in case of HD.
Other diseases (e.g. most cases of AD) occur sporadically, so
that triggering mechanisms remain unknown. Some amyloi-
doses (including AD) are clearly age-dependent, pointing to
a potential connection between amyloid formation and aging.
Therefore, the importance of these diseases grows dramatically
with eradication of other diseases and increase of life expec-
tancy in the human populations. It is worth mentioning that
prion diseases and many other amyloidoses (including AD
and HD) remain fatal and incurable thus far. Without any
exaggeration, it is easy to forecast that AD and similar disor-
ders have a potential of becoming the major cause of death for
the next generations of humans.
Lower eukaryotes, such as yeast and other fungi, also con-
tain self-perpetuating transmissible amyloids that possess
prion-like properties (for review, see [4–6]). These amyloids
manifest themselves as non-Mendelian elements that control
speciﬁc traits, heritable in cell generations and infectious via
cytoplasmic exchange. Although fungal amyloid-forming pro-
teins are not homologous to mammalian PrP, they are also
usually termed ‘‘prion proteins’’. Fungal prions do not neces-
sarily kill their carriers. However, recent data demonstrate that
at least some fungal prions are pathogenic to a certain extent
(reviewed in [4,7]).
In the yeast Saccharomyces cerevisiae, several proteins have
been proven to generate self-perpetuating amyloid-based pri-
ons. These include: (1) translational termination factor
Sup35 (also called eRF3); (2) regulatory protein in the nitrogen
metabolism pathway, Ure2; (3) protein of unknown function,
Rnq1 (for review, see [4–7]). Prion forms of these proteins
are termed [PSI+], [URE3] and [PIN+] (or [RNQ+]), respec-
tively. Yeast prion proteins contain N-terminal or C-terminal
regions, termed prion domains or PrDs, that are required
and suﬃcient for prion formation and propagation, and are
dispensable for the normal cellular function of a prion protein
in cases when this function is known (for review, see [5,6]).
While known yeast prion proteins are not homologous to each
other, they contain common sequence elements, some of which
also resemble certain regions of mammalian amyloidogenic
proteins. For example, all known yeast PrDs contain QN-rich
stretches that are similar to the poly-Q stretch of mammalian
huntingtin, and some yeast PrDs contain oligopeptide repeats
(ORs) similar to those found in mammalian PrP (reviewed in
[4–6]). Mechanisms of amyloid formation in yeast and other
fungi appear to be very similar to those described in mamma-
lian systems. Therefore, yeast prions provide easy and eﬃcient
experimental assays for studying the factors and conditions
inﬂuencing amyloid formation and propagation.blished by Elsevier B.V. All rights reserved.
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whether cellular defense systems aimed at protecting the cells
from aggregation of stress-damaged proteins can also recognize
amyloids. This review summarizes data, obtained in the yeast
models, that implicate stress-related proteins as major modula-
tors of amyloid formation and propagation in a eukaryotic cell.
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Fig. 1. Role of Hsp104 in propagation of the prion form of Sup35.
Non-prion isoform (soluble monomer) is designated as a circle, prion
isoform (unit of an amyloid polymer) – as a rectangle. (A) At low levels
(or activity) of Hsp104, or in case of the amyloid aggregate which is
insensitive to Hsp104, a polymer stays in the mother cell and is
growing in an uncontrollable fashion, possibly resulting in the eventual
death of the polymer-containing cell. A daughter cell which does not
get an amyloid ‘‘seed’’ after the cell division produces de novo
synthesized protein in a non-prion form. (B) At normal levels of
Hsp104, initial polymer is being broken into oligomeric ‘‘seeds’’, that
are transmitted to both cells after cell division and initiate new rounds
of prion propagation. (C) At high levels of Hsp104, amyloid polymers
are solubilized into monomers, that are converted into a non-prion
form. Note that for the sake of simplicity, fate of only one initial
polymer is followed on each part of the ﬁgure (A, B or C). In a reality,
each prion-bearing cell usually contains a number of propagating
polymers. Therefore, both prion loss and mother cell death depicted in
part A should normally occur only after several cell divisions in the
conditions where disaggregation is impaired. See text for details and
references.2. Role of heat shock proteins in formation and propagation of
the yeast prions
2.1. Role of Hsp104 in prion propagation
The ﬁrst evidence connecting a component of the cellular
stress defense system to a prion was obtained in yeast. A prion
isoform of the yeast protein Sup35 was shown to be main-
tained only at certain levels of the chaperone protein Hsp104
[8]. If Hsp104 was inactivated or overproduced, the initially
prion-containing culture ([PSI+]) produced cells containing
only a non-prion isoform of Sup35 ([psi]). Later, it was shown
that intact Hsp104 is also required for the maintenance of all
other known yeast prions, even though prion forms of the pro-
teins other than Sup35 are not ‘‘cured’’ by Hsp104 overpro-
duction (for review, see [9]).
Hsp104, a member of the evolutionarily conserved Clp/
Hsp100 family and a yeast counterpart of bacterial ClpB, is
a stress-inducible chaperone that functions as a homohexamer
and promotes solubilization of the aggregated misfolded pro-
teins and in this way, protects yeast cells from heat shock
and some other environmental stresses (for review, see [9]).
One possibility is that Hsp104 is required for ‘‘shearing’’ prion
aggregates into smaller oligomeric ‘‘seeds’’, initiating new
rounds of prion propagation [10] (Fig. 1). Indeed, the immedi-
ate consequence of Hsp104 inactivation in the prion-contain-
ing cells is an increase in the size of Sup35 aggregates
[11,12]. Moreover, the prion isoforms of Sup35 that are main-
tained only at high levels of Hsp104 were either generated by
genetic alterations of the Sup35 protein [13] or found among
various prion ‘‘variants’’ (or ‘‘strains’’) generated by the intact
Sup35 protein [14], and were shown in both cases to form
abnormally large aggregates.
On the other hand, results of the direct biochemical experi-
ments aimed at studying interactions between Hsp104 and
prion proteins such as Sup35 remain somewhat contradictory.
While some data indicate that Hsp104 can indeed break
Sup35-based aggregates in vitro producing oligomeric ‘‘seeds’’
[15], other results disagree [16] or suggest that Hsp104 only
does this with the help of the other chaperones [17]. There is
evidence that Hsp104 somewhat promotes initial aggregation
of the yeast prion proteins in vitro [15], an observation that
has not so far been conﬁrmed in vivo.
A number of the mutant derivatives of Hsp104 have been
checked for their eﬀects on thermotolerance and prion mainte-
nance (reviewed in [9]). In most cases, mutations aﬀecting ther-
motolerance also aﬀected prion maintenance, and vice versa.
However, several exceptions of this rule were described (e.g.
[18]). Interestingly, the majority of Hsp104 mutations aﬀecting
maintenance of the Sup35 prion but not thermotolerance arise
from substitutions of amino acids located along the lateral
channel of the Hsp104 hexamer [19]. This suggests that a lat-
eral channel may play a speciﬁc role in the interaction of the
Hsp104 hexamer with prion aggregates.2.2. Regions of Sup35 involved in interactions with Hsp104
Despite clear and indisputable evidence conﬁrming the cru-
cial role of Hsp104 in prion propagation, numerous attempts
to prove in vivo physical interactions between Hsp104 and
prion proteins such as Sup35 failed (for example, see [20]),
while in vitro results were contradictory (for examples, see
[15–17]). It is likely that Hsp104 speciﬁcally recognizes only
the aggregated form of a prion protein, and its interaction
with such an aggregate is of a transient nature, so that it
breaks the aggregate and dissociates from it. The question
arises whether Hsp104 recognizes any speciﬁc region of a
prion protein within the aggregate. Based on the considerable
experimental evidence, it has been proposed that PrDs of the
yeast prion proteins can be subdivided into ‘‘aggregation’’ and
‘‘propagation’’ modules (Fig. 2; for review, see [6]). In case of
Sup35, the ‘‘aggregation’’ module appears to correspond to
the N-terminal QN-rich stretch, while the adjacent region of
oligopeptide repeats is required for the eﬃcient propagation
of the prion state in vivo [21]. As prion propagation is
achieved via breakage of aggregates by Hsp104 (see above),
the simplest possibility appeared to be that the repetitive
structure is recognized by Hsp104. However, some yeast pri-
ons (e. g. Ure2) do not have repeats. Moreover, reshuﬄing
of the Sup35 PrD sequence that eliminated the repetitive pat-
tern of its organization did not eliminate the prion-propagat-
ing ability [22]. Apparently, even if the region of repeats is
indeed involved in interaction with Hsp104, its repetitive orga-
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Fig. 2. Structural and functional organization of Sup35 protein and Sup35 prion aggregates. (A) Structural and functional organization of the
Saccharomyces cerevisiae Sup35 protein. Sup35N, Sup35M and Sup35C refer to the N-proximal, middle and C-proximal regions, respectively.
Sup35N is a prion domain, while Sup35C is a release factor domain responsible for the major cellular function of Sup35 (termination of translation).
QN – glutamine/asparagine-rich stretch, OR – oligopeptide repeats. Numbers correspond to amino acid positions. N/M boundary is arbitrarily
chosen, as diﬀerent data conﬁned it to diﬀerent positions between the amino acid residues 113 and 137 (for review, see [6]). (B) Structural
organization of the Sup35 amyloid ﬁber. The axis of a ﬁber is kept together by intermolecular cross-b interactions between the prion domains, while
Sup35C regions are exposed on the side of a ﬁber. An Hsp104 hexamer invades the axis and initiates breakage of a ﬁber, presumably via interactions
that involve a lateral channel of the hexamer. It is not yet clear which exact parts of Sup35N (and possibly Sup35M) are involved in axis formation
and/or binding of Hsp104 (see text for more details).
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explanation could be that the ‘‘propagation’’ module inﬂu-
ences some patterns of aggregates that control accessibility
by Hsp104, but does not physically interact with a chaperone
on its own. Another region of Sup35 suspected to either di-
rectly or indirectly interact with Hsp104 is the middle (M) re-
gion. This region, containing a high concentration of charged
residues, is required for neither normal cellular function of the
Sup35 protein (that is, translational termination) nor prion
formation and maintenance (reviewed in [5,6]). However, re-
cent studies indicate that at least some residues of Sup35M
are involved in interactions within the amyloid ﬁber [23]. This
agrees with the observation that certain alterations of the M
region change patterns of the Hsp104 dependence [24]. More-
over, prions formed in S. cerevisiae by the Sup35 protein of
the closely related species S. paradoxus that contains a diver-
gent (87% of amino acid identity) M region possess a propa-
gation defect, which is eliminated in case if the M region of
S. paradoxus is substituted by the M region of S. cerevisiae
[25]. As of now, the exact target region of Sup35 recognized
by Hsp104 remains unknown.2.3. Eﬀects of the Hsp70 and Hsp40 proteins on yeast prions
The Hsp70 and Hsp40 chaperones assist Hsp104 in protect-
ing yeast cells from environmental stresses: while Hsp104 is
thought to promote disaggregation and solubilization of the
stress-damaged proteins, Hsp70 with the help of Hsp40 is
thought to refold these proteins back into their native state
[26]. Hsp70 is also shown to play a crucial role in the propaga-
tion of yeast prions, speciﬁcally of the prion forms of Sup35and Ure2 (for detailed review, see [9]). Interestingly, diﬀerent
members of the yeast Hsp70 family have diﬀerent eﬀects on
the prion form of Sup35. The proteins of the stress-inducible
Ssa subfamily generally aid in propagation of the Sup35 prion,
while proteins of the constitutively expressed Ssb subfamily
manifest themselves as prion antagonists. These diﬀerences
are determined, in a signiﬁcant part, by the peptide-binding
domains of these chaperones [20]. Both Ssa and Ssb are shown
to interact with Sup35 directly.
Despite signiﬁcant amount of mutational analysis data,
accumulated especially in D. Masison lab, molecular mecha-
nism of the Hsp70 eﬀect on yeast prions remains unclear (for
recent models, see [9]) . Even less is known about the role of
Hsp40 proteins, usually acting as co-chaperones of Hsp70s.
Two Hsp40 co-chaperones of Ssa, Ydj1 and Sis1, exhibit diﬀer-
ential eﬀects on prion forms of some yeast proteins, such as
Rnq1 [27] and Ure2 [28], as well as on polyglutamine aggre-
gates produced in yeast [29].
Overall, existing evidence indicates that proteins of the same
complex that is involved in protection of the yeast cells against
aggregates of the stress-damaged proteins (Hsp104, Hsp70 and
Hsp40) also play a crucial role in propagation of prion aggre-
gates. It appears that the balance between the components of
this complex is a key regulator of prion propagation, as
increased production of Hsp70-Ssa can ameliorate the ability
of overproduced Hsp104 to eliminate the Sup35 prion
[20,30]. Thus, prions employ chaperone machinery of a yeast
cell for the purpose of their own propagation, and alteration
of the chaperone balance can modulate acquisition or loss of
the prion state. As Hsp levels and balance are regulated by
environmental and physiological stresses, these data provide
3698 Y.O. Chernoﬀ / FEBS Letters 581 (2007) 3695–3701a molecular mechanism connecting stress to amyloid-like
aggregation.1G. Newnam and Y. Chernoﬀ, in preparation.3. Yeast prions and proteolytic pathways
As an alternative to refolding, cells can eliminate stress-dam-
aged proteins via proteolytic degradation. Two major proteo-
lytic systems are responsible for protein degradation in a
eukaryotic cell (for review, see [31]): (1) ubiquitin-proteasome
system (UPS); (2) lysosome, or (in yeast) vacuole. Cytoplasmic
proteins are usually degraded by UPS, but can also be directed
to the lysosome/vacuole via starvation-induced or stress-in-
duced process called autophagy [32]. Misfolded proteins are
targeted for proteasomal degradation via covalent attachment
of ‘‘tails’’ composed of a polymerized small protein called
ubiquitin. Mono- or polyubiquitin attachment is also involved
in targeting some proteins for lysosomal/vacuolar degradation,
as well as in regulation of protein activity and directing pro-
teins to some non-degradative fates. Eﬃciency and speciﬁcity
of ubiquitination is controlled by a variety of ubiquitin-conju-
gating enzymes (E2) and ubiquitin ligases (E3). In yeast, the
vast majority of protein ubiquitination during stress is medi-
ated by the related ubiquitin-conjugating enzymes Ubc4 and
Ubc5 [33].
Little is known about degradation of prions and other amy-
loid aggregates in eukaryotic cells. It is unlikely that the pro-
teasome is capable of degrading huge protein aggregates.
Moreover, some amyloidogenic proteins such as polygluta-
mines are not eﬃciently degraded by proteasomes even in a
monomeric state [34]. On the other hand, accumulation of
amyloidogenic proteins overwhelms UPS, that induces forma-
tion of so-called aggresomes, huge complexes assembled with
the help of cytoskeletal structures and apparently sequestering
ubiquitin and other UPS components [35]. Autophagy appears
to be involved in aggresome degradation when UPS function is
inhibited [36].
In yeast, alterations of some UPS components, speciﬁcally
deletion of the gene coding for the major ubiquitin-conjugat-
ing enzyme Ubc4, decrease the loss of a prion state of the
Sup35 protein in the presence of excess Hsp104 and increase
spontaneous de novo formation of the Sup35 prion [37].
Once again, the same UPS component that plays a major
role during environmental stress also modulates prion behav-
ior. Interestingly, deletion of the gene coding for the enzyme
Ubc5, that is functionally similar to Ubc4, does not appear
to increase spontaneous prion formation. It is not clear
whether this diﬀerence reﬂects diﬀerent functional speciﬁcities
of Ubc4 and Ubc5 or diﬀerent modes of their expression: it
is possible that eﬀects on the prion are most pronounced at
the stage when Ubc4 rather than Ubc5 is predominantly
present.
Mechanism of the UPS eﬀect on a yeast prion remains un-
clear. The simplest explanation would be that impairment of
ubiquitin-mediated degradation increases accumulation of
misfolded protein which is directed to prion aggregates. How-
ever, evidence for the direct ubiquitination and UPS-directed
degradation of Sup35 is lacking thus far. It is therefore possi-
ble that Ubc4 and other UPS components modulate prion for-
mation and maintenance via ubiquitination of some auxiliary
components that inﬂuence Sup35 protein. Indeed, some of
the chaperones involved in prion propagation (for example,some members of the Hsp70 family) as well as some other
prion proteins (for example, Rnq1) are found among ubiquiti-
nation targets [38], and eﬀect of the ubc4 deletion on de novo
formation of the Sup35 prion depends on Rnq1 [37]. Another
possibility is that UPS defect induces ‘‘aggresome’’ formation
that may in fact promote prion aggregation. Aggresome-like
complexes of Sup35 co-localized with some components of
the cytoskeletal networks are indeed identiﬁed in the yeast cells
[39], although they appear to interact with cortical actin net-
works rather than with microtubules implicated in the assem-
bly of mammalian aggresomes. Moreover, formation of some
types of these cytologically detectable Sup35 inclusions is
apparently elevated in the ubc4 deletion strains [37]. It is worth
noting that two explanations of the Ubc4 role in prion forma-
tion and maintenance that were mentioned above are not
mutually exclusive. Further experiments are needed to deci-
pher the molecular pathway connecting UPS to yeast prions,
as well as to determine whether and how prion aggregates
are degraded in the yeast cell.4. Prions and environmental stresses
As components of the cellular stress-defense systems modu-
late prion formation and propagation in yeast, the question
arises whether environmental stress can lead to prion appear-
ance or elimination. Detailed study performed in B. Cox’s
lab (reviewed in [40]) indicates that at least the prion form of
Sup35 can be eliminated (‘‘cured’’) by some environmental
stresses, such as severe heat shock, ethanol or methanol stress,
and some osmotic stressors. Moreover, mutational alteration
of the Hsp70 chaperone Ssa1 increases susceptibility of the
Sup35 prion to heat shock [41]. Our recent data1 demonstrate
that eﬃcient elimination of the Sup35 prion is observed only
during short-term heat shock, while longer exposure to the
high temperature treatment results in prion recovery. More-
over, both prion elimination and prion recovery coincide,
respectively, with alteration and restoration of the balance be-
tween the major chaperones shown to be involved in prion
propagation. These data indicate that chaperone balance regu-
lates maintenance of the Sup35 prion not only during normal
growth but also in the stress conditions. Whether this is appli-
cable to other yeast prions, remains to be seen.
Less is known about environmental conditions that can pro-
mote de novo prion formation. One treatment clearly demon-
strated thus far to do so is long-term storage of the starving
yeast culture in the refrigerator, that induces generation of
the prion forms of Ure2, Rnq1 and Sup35 (reviewed in [5]).
Molecular mechanisms of this phenomenon have not been
investigated. Starving non-dividing cells are likely to accumu-
late increased amounts of aggregated proteins, while modiﬁca-
tion of the chaperone expression patterns at low temperature
may provide intracellular environment that favors aggregate
conversion into self-perpetuating prions. However, it is still
to be determined which chaperones are involved in the process
in this speciﬁc case. It is known that depletion of the Ssb chap-
erone of Hsp70 family [42] or increased levels of the Ssa pro-
teins of the same family [20] facilitate formation of the
Sup35 prion. Also, alterations of heat shock factor, that
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the de novo formation of the Sup35 prion [43]. However, it is
still unknown whether (and which) chaperones contribute to
the prion-inducing eﬀect of low temperature.
There was also a report of increased formation of the Ure2
prion in the presence of the antibiotic G418 that induces trans-
lational errors [44]. Once again, it remains to be seen whether
this is a direct consequence of the accumulation of a misfolded
protein in result of mistranslation, or this eﬀect is mediated by
stress-related proteins induced in response to it.5. Parallels and diﬀerences between yeast and animal amyloids
and inclusions
As yeast prion propagation is controlled by prion proteins
and inﬂuenced by environmental stresses, the question arises
whether the same is true for prions and other amyloid-like
aggregates found in mammals and other animals. Yeast chap-
erones involved in propagation of the endogenous yeast pri-
ons, speciﬁcally members of the Hsp40 family (Ydj1 and
Sis1) and some mutant derivatives of Hsp104, are also shown
to inﬂuence aggregation and toxicity of mammalian polygluta-
mines in yeast, as demonstrated for the N-terminal fragment of
human huntingtin, containing the expansion of the polygluta-
mine stretch and expressed in the yeast strain with an endoge-
nous QN-rich prion, apparently providing the initial nucleus
for huntingtin aggregation [29]. Moreover, some eﬀects of
Sis1 and Ydj1 observed in yeast parallel the eﬀects of their
mammalian orthologs, Hdj1 and Hdj2, respectively, detected
in the animal models for polyglutamine disorders [45,46]. Rela-
tionship between stress-related proteins and polyglutamine
aggregation is also established in the nematode Caenorhabditis
elegans (for review, see [47]). Remarkably, introduction of
yeast Hsp104 can counteract polyglutamine aggregation in
nematode [48]. These data conﬁrm that at least some patterns
of interactions between chaperones and amyloids or amyloid-
like inclusions are conserved between yeast and animals, and
further signify importance of the yeast-based model for study-
ing the chaperone eﬀects on amyloidogenic and prion-forming
proteins.
On the other hand, animal genomes sequenced to date lack
the ortholog of yeast Hsp104, even though such orthologs are
found in plants and even bacteria. It is not yet clear which pro-
tein plays the role of Hsp104 in protection of mammalian cells
against aggregates of stress-damaged proteins. Although alter-
ations in expression and distribution of some cytoplasmic heat
shock proteins, e.g. mammalian members of the Hsp70 family,
are associated with the infection by PrP prion in the mamma-
lian systems (for review, see [49]), it remains to be determined
whether these chaperones inﬂuence formation and/or propaga-
tion of the prion form of PrP. The matter is further compli-
cated by the fact that PrP is, at least in its non-prion form,
an extracellular protein. It is therefore possible that other
chaperone proteins, expressed in compartments that are asso-
ciated with the secretory or endocytic pathways, take Hsp104’s
place in ‘‘breaking’’ the mammalian prion aggregates and con-
verting them to infectious prion units. However, recent data
also indicate that alterations in Hsp levels are associated with
toxicity of certain intracellular amyloids, for example in the
case of Parkinson disease (for review, see [49]). Moreover,one should note that mammalian genomes contain a signiﬁcant
number of proteins with QN-rich regions similar to yeast
PrDs. It cannot be ruled out that some of these proteins can
form intracellular prions, controlled by the cytoplasmic chap-
erones in a yeast-like fashion.6. Stress and possible biological roles of prions
Intimate involvement of some stress-related proteins in
prion formation and/or propagation, as well as eﬀects of envi-
ronmental stresses on yeast prions suggest a possible explana-
tion for the conservation of prion domains in evolution.
Indeed, the N-proximal domain of Sup35 (which behaves as
PrD in yeast) is present in the majority of organisms studied,
despite its apparent dispensability for the major cellular func-
tion of Sup35 in termination of translation (reviewed in [7]).
Moreover, although PrD region evolves faster than the func-
tional part of Sup35 protein, PrD amino acid sequence still re-
mains under the purifying selection pressure, indicating that
this portion of Sup35 plays a certain adaptive role. Although
it has been suggested that the prion form of Sup35, which is
defective in termination, could play an adaptive role by allow-
ing readthrough of open reading frames interrupted by non-
sense-mutations, such a model was challenged by the data
indicating that Sup35 prion can not be found in the natural
populations of yeast (for review, see [4,7]). Moreover, such a
mechanism could not apply to other yeast prions that have
nothing to do with translation. On the other hand, it is possible
that adaptive functions are performed by metastable prion
variants that persist only in certain conditions and are con-
verted back to a non-prion form after conditions are changed.
Recent data provide a proof of existence of the metastable var-
iant of the Sup35 prion that can be maintained only at high
levels of the Hsp104 chaperone [14]. One could suggest that
metastable or reversible aggregates of prion-like type are used
to preserve certain proteins through unfavorable periods, so
that such proteins could be quickly activated after conditions
change back to normal and regular cellular metabolism is
resumed. Indeed, such a mechanism is demonstrated in mam-
malian cells for the so-called stress granules, huge complexes
containing mRNAs, associated with the small ribosomal
subunits and some translation initiation factors, that are tran-
siently assembled during stresses (such as heat shock) in order
to protect these components from stress-induced damage.
Remarkably, protein TIA-1 involved in assembly of stress
granules contains a QN-rich domain which is needed for the
granule formation, resembles PrD of Sup35 and can be func-
tionally substituted by attachment of Sup35 PrD to the TIA-
1 protein lacking this domain [50]. As Sup35 is an important
protein that also has to be present in the active form immedi-
ately after the stress is over, it seems logical to propose that
reversible formation of the ordered aggregates of Sup35, med-
iated by its PrD, could protect this protein from damage and
destruction during stress conditions. Both aggregation and
subsequent disaggregation of Sup35 would have to be medi-
ated by stress-regulated chaperones, that could explain emer-
gence of the ‘‘prion propagation machinery’’, composed of
Hsp104, Hsp70 and Hsp40, in the yeast cell, and of equivalents
of this machinery (if found) in other eukaryotic cells. Increased
prion formation in the starving cells kept at low temperature
Normal conditions Normal conditionsUnfavorable conditions
Hsps? Hsp104
Prion
formation
Hsp104
CSK?
Prion propagation
Hsp104
Fig. 3. Model for the biological role of prion-like aggregation. At normal conditions, a prion-forming protein exists as a soluble monomer and
perform its normal cellular function. In certain unfavorable conditions, ordered protein complexes are formed via interactions between prion
domains (designated as ﬁlled ovals). Formation of these complexes, which is possibly assisted by some Hsps and/or cytoskeletal assembly proteins
(CSK), downregulates the enzymatic function of a prion-forming protein and protects this protein from damage and destruction. Upon return to
normal conditions, complexes are solubilized by Hsp104, so that a prion-forming protein is converted back into the active state. However, prion
polymers can be occasionally generated as by-products of such protective aggregation. These prion polymers are no longer solubilized to monomers
at normal levels of Hsp104. Instead, they undergo repetitive breakage and propagation cycles as shown in more detail in Fig. 1.
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Sup35 in these conditions. In such a model, stably inherited
(irreversible) prions would represent ‘‘diseases’’ originated as
rare by-products of generally reversible protective aggregation
(Fig. 3). Such a mechanism could also apply to other prion-
forming proteins, assuming they are playing certain roles
(not necessarily essential roles) in the cells during (or immedi-
ately following) recovery from stress.
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